chronic lymphocytic leukemia

Showing 1 - 25 of 506

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 14, 2022

DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +3 more
  • Louisville, Kentucky
  • +6 more
Nov 14, 2022

B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

Not yet recruiting
  • B-cell Malignancy
  • +7 more
  • (no location specified)
Oct 26, 2022

HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (BNT162b2, mRNA-1273, NVX-COV2373)

Not yet recruiting
  • HIV
  • +5 more
  • BNT162b2
  • +2 more
  • Melbourne, Victoria, Australia
    Alfred Health
Sep 25, 2022

Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • (no location specified)
    Sep 23, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Obinutuzumab
    • +3 more
    • Birmingham, Alabama
    • +484 more
    Aug 24, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Mantle Cell Lymphoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 22, 2022

    DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • +2 more
    • New Haven, Connecticut
    • +2 more
    Aug 22, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Fountain Valley, California
    • +201 more
    Aug 18, 2022

    Chronic Lymphocytic Leukemia Trial in Boston, Hackensack, New York (Ublituximab, Umbralisib, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
    • +2 more
    Aug 19, 2022

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Chicago, Illinois
    • +2 more
    Aug 19, 2022

    Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

    Active, not recruiting
    • Relapsed/Refractory B Cell Malignancies
    • +3 more
    • Columbus, Ohio
    • +17 more
    Aug 18, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Obinutuzumab
    • +3 more
    • Huntsville, Alabama
    • +153 more
    Aug 19, 2022

    SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Biospecimen Collection
    • Electronic Health Record Review
    • Duarte, California
    • +11 more
    Aug 16, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spokane, Salamanca (Zilovertamab vedotin,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Spokane, Washington
    • +1 more
    Aug 12, 2022

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +26 more
    Aug 11, 2022

    B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

    Recruiting
    • B-Cell Lymphoma
    • +8 more
    • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
    • Pittsburgh, Pennsylvania
      AHN Cancer Institute - West Penn Hospital
    Aug 10, 2022

    Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Chronic Lymphocytic Leukemia
    • Stony Brook, New York
    • +27 more
    Aug 11, 2022

    Chronic Lymphocytic Leukemia, Hypogammaglobulinemia Trial in Worldwide (Panzyga, Placebo)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Hypogammaglobulinemia
    • Panzyga
    • Placebo
    • Saint Petersburg, Florida
    • +52 more
    Aug 10, 2022

    Treatment Pathway in Chronic Lymphocytic Leukemia

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Argentina, Argentina
      • +17 more
      Aug 9, 2022

      Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Whittier, California
        Innovative Clinical Research Institute
      Aug 8, 2022

      Financial Difficulty in Patients With Blood Cancer

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Multiple Myeloma
        • Chapel Hill, North Carolina
          UNC Medical Center
        Aug 9, 2022

        Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

        Recruiting
        • Relapsed Non Hodgkin Lymphoma
        • +6 more
        • Cincinnati, Ohio
        • +4 more
        Aug 3, 2022

        Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

        Not yet recruiting
        • Colorectal Cancer
        • +11 more
        • Cleveland, Ohio
          University Hospitals Cleveland Medical Center, Case Comprehensiv
        Aug 2, 2022